Magnetic resonance spectroscopy in niemann-pick disease type C: Correlation with diagnosis and clinical response to cholestyramine and lovastatin
- 31 May 1994
- journal article
- case report
- Published by Elsevier in Pediatric Neurology
- Vol. 10 (3) , 228-232
- https://doi.org/10.1016/0887-8994(94)90028-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopyPediatric Neurology, 1992
- Niemann‐Pick disease type C: An updateJournal of Inherited Metabolic Disease, 1991
- Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatineAnnals of Neurology, 1990
- Type C Niemann-Pick disease: dimethyl sulfoxide moderates abnormal LDL-cholesterol processing in mutant fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Clinical Improvement with DMSO Treatment in a Patient with Niemann‐Pick Disease (Type C)Pediatrics International, 1988
- Niemann-Pick disease type CActa Neuropathologica, 1985
- A Progressive Neurologic Disorder With Supranuclear Vertical Gaze Paresis and Distinctive Bone Marrow CellsMayo Clinic Proceedings, 1984
- Biochemical studies in niemann-pick disease I. Major sphingolipids of liver and spleenBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- The DAF syndromeNeuro-Ophthalmology, 1981
- A NEUROVISCERAL STORAGE DISEASE WITH VERTICAL SUPRANUCLEAR OPHTHALMOPLEGIA, AND ITS RELATIONSHIP TO NIEMANN-PICK DISEASEBrain, 1973